3vap: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "3vap" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 3: | Line 3: | ||
The entry 3vap is ON HOLD | The entry 3vap is ON HOLD | ||
Authors: Voss, M. E., Rainka, M. P., Fleming, M., Peterson, L. H., Belanger, D. B., Siddiqui, M. A., Hruza, A., Voigt, J., Basso, A. D., Gray, K. | Authors: Voss, M.E., Rainka, M.P., Fleming, M., Peterson, L.H., Belanger, D.B., Siddiqui, M.A., Hruza, A., Voigt, J., Basso, A.D., Gray, K. | ||
Description: Synthesis and SAR Studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off target kinase selectivity | Description: Synthesis and SAR Studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off target kinase selectivity | ||
Revision as of 05:59, 11 January 2012
Unreleased structure
The entry 3vap is ON HOLD
Authors: Voss, M.E., Rainka, M.P., Fleming, M., Peterson, L.H., Belanger, D.B., Siddiqui, M.A., Hruza, A., Voigt, J., Basso, A.D., Gray, K.
Description: Synthesis and SAR Studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off target kinase selectivity
